UK markets open in 35 minutes
NIKKEI 225
38,835.10 +599.03 (+1.57%) HANG SENG
18,476.74 -101.56 (-0.55%) CRUDE OIL
78.62 +0.14 (+0.18%) GOLD FUTURES
2,328.30 -2.90 (-0.12%) DOW
38,852.27 +176.59 (+0.46%) Bitcoin GBP
50,704.32 -589.07 (-1.15%)
Amneal Pharmaceuticals, Inc. (AMRX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.05B |
| Enterprise value | 4.75B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.57 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 1.90 |
| Enterprise value/EBITDA | 13.68 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.35 |
| 52-week change 3 | 263.44% |
| S&P500 52-week change 3 | 24.49% |
| 52-week high 3 | 6.90 |
| 52-week low 3 | 1.74 |
| 50-day moving average 3 | 5.75 |
| 200-day moving average 3 | 4.84 |
Share statistics
| Avg vol (3-month) 3 | 1.66M |
| Avg vol (10-day) 3 | 2.12M |
| Shares outstanding 5 | 308.55M |
| Implied shares outstanding 6 | 313.66M |
| Float 8 | 135.81M |
| % held by insiders 1 | 55.79% |
| % held by institutions 1 | 29.20% |
| Shares short (15 Apr 2024) 4 | 2.8M |
| Short ratio (15 Apr 2024) 4 | 1.58 |
| Short % of float (15 Apr 2024) 4 | 1.09% |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.91% |
| Shares short (prior month 15 Mar 2024) 4 | 2.07M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -6.76% |
| Operating margin (ttm) | 13.13% |
Management effectiveness
| Return on assets (ttm) | 5.60% |
| Return on equity (ttm) | -165.27% |
Income statement
| Revenue (ttm) | 2.5B |
| Revenue per share (ttm) | 11.61 |
| Quarterly revenue growth (yoy) | 18.20% |
| Gross profit (ttm) | N/A |
| EBITDA | 544.36M |
| Net income avi to common (ttm) | -168.69M |
| Diluted EPS (ttm) | -0.73 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 46.52M |
| Total cash per share (mrq) | 0.15 |
| Total debt (mrq) | 2.75B |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 1.65 |
| Book value per share (mrq) | -0.21 |
Cash flow statement
| Operating cash flow (ttm) | 201.46M |
| Levered free cash flow (ttm) | 111.63M |
© 2024 Yahoo. All rights reserved.